PANACEABIO

PANACEA BIOTEC

Small Cap BSE: 531349 NSE: PANACEABIO
₹138.8
0.75 (0.54%)
As on 09 August, 2022 | 17:01

Panacea Biotec Share Price

Panacea Biotec Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Panacea Biotec Share Returns

  • Over 1 Month 6.81%
  • Over 3 Month -5.58%
  • Over 6 Month -35.71%
  • Over 1 Year -60.07%

Panacea Biotec Key Statistics

P/E Ratio -9.1
PEG Ratio 0
Market Cap Cr 850
Price to Book Ratio 67.8
EPS -15.3
Dividend 0
Relative Strength Index 59.5
Money Flow Index 71.52
MACD Signal 0.01
Average True Range 5

Panacea Biotec Investment Rating

  • Master Rating:
  • Panacea Biotec (Nse) has an operating revenue of Rs. 661.23 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 219% is great, ROE of 126% is exceptional. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 41 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Panacea Biotec Financials
  • Indicator
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 42
  • 38
  • 119
  • 36
  • 80
  • Operating Expenses Qtr Cr
  • 61
  • 55
  • 137
  • 56
  • 96
  • Operating Profit Qtr Cr
  • -19
  • -16
  • -17
  • -19
  • -16
  • Depreciation Qtr Cr
  • 7
  • 6
  • 6
  • 6
  • 7
  • Interest Qtr Cr
  • 1
  • 2
  • 2
  • 2
  • 2
  • Tax Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 2
  • Net Profit Qtr Cr
  • -25
  • -22
  • -22
  • -23
  • -18

Panacea Biotec Technicals

EMA & SMA

Current Price
138.8
0.75 (0.54%)
  • Bullish Moving Average
  • ___
  • 10
  • Bearish Moving Average
  • ___
  • 6
  • 20 Day
  • 133.72
  • 50 Day
  • 136.89
  • 100 Day
  • 148.81
  • 200 Day
  • 176.02
  • 20 Day
  • 131.71
  • 50 Day
  • 134.25
  • 100 Day
  • 148.16
  • 200 Day
  • 175.85

Panacea Biotec Resistance and Support

PIVOT
₹138.65
Resistance
  • First Resistance
  • 140
  • Second Resistance
  • 141.95
  • Third Resistance
  • 143.31
Support
  • First Resistance
  • 136.7
  • Second Resistance
  • 135.35
  • Third Resistance
  • 133.4
  • RSI
  • 59.5
  • MFI
  • 71.52
  • MACD Single Line
  • 0.01
  • MACD
  • 1.56

Panacea Biotec Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 57,898
  • 3,196,549
  • 55.21
  • Week
  • 191,386
  • 6,878,406
  • 35.94
  • 1 Month
  • 83,071
  • 4,220,842
  • 50.81
  • 6 Month
  • 111,252
  • 6,510,478
  • 58.52

Panacea Biotec Result Highlights

Panacea Biotec Synopsis

NSE-Medical-Generic Drugs

Panacea Biotec L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 343.56 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2021. Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350.
  • Market Cap
  • 850
  • Sales
  • 236
  • Shares in Float
  • 1.59
  • No of funds
  • 1
  • Yield
  • Book Value
  • 2.05
  • U/D Vol ratio
  • 1
  • LTDebt / Equity
  • 20
  • Alpha
  • -0.33
  • Beta
  • 0.78

Panacea Biotec

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 73.59%
  • 73.59%
  • 73.59%
  • Foreign Portfolio Investors
  • Individual Investors
  • 15.6%
  • 15.14%
  • 16%
  • Others
  • 10.81%
  • 11.27%
  • 10.41%

Panacea Biotec Management

  • Name
  • Designation
  • Mr. Soshil Kumar Jain
  • Chairman
  • Dr. Rajesh Jain
  • Managing Director
  • Mr. Sandeep Jain
  • Joint Managing Director
  • Mr. Ankesh Jain
  • Director - Sales & Marketing
  • Mr. R L Narasimhan
  • Non Executive Director
  • Mr. N N Khamitkar
  • Non Executive Director
  • Mr. K M Lal
  • Non Executive Director
  • Mrs. Manjula Upadhyay
  • Non Executive Director
  • Mr. Bhupinder Singh
  • Non Executive Director
  • Mr. Shantanu Yeshwant Nalavadi
  • Non Executive Director

Panacea Biotec Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Panacea Biotec Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-09
  • Quarterly Results
  • 2022-05-18
  • Audited Results
  • 2022-02-14
  • Quarterly Results
  • 2022-02-01
  • Others
  • To consider Fund Raising
  • 2021-11-12
  • Quarterly Results

Panacea Biotec MF Shareholding

  • Name
  • Amount(cr)
  • ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
  • 2417

Panacea Biotec FAQs

What is Share Price of Panacea Biotec ?

Panacea Biotec share price is ₹138 As on 09 August, 2022 | 16:47

What is the Market Cap of Panacea Biotec ?

The Market Cap of Panacea Biotec is ₹850.2 Cr As on 09 August, 2022 | 16:47

What is the P/E ratio of Panacea Biotec ?

The P/E ratio of Panacea Biotec is 0.8 As on 09 August, 2022 | 16:47

What is the PB ratio of Panacea Biotec ?

The PB ratio of Panacea Biotec is 1 As on 09 August, 2022 | 16:47

Q1FY23